Dedicated to research for animals.




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Dedicated to research for animals.
Released on: June 05, 2015. © PTV
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Dr Joachim Hasenmaier, Corporate Board Divisions Animal Health and Consumer Healthcare at Boehringer Ingelheim
  • Summary
  • Transcript
  • Participants
  • Company
Dr Joachim Hasenmaier, Corporate Board Divisions Animal Health and Consumer Healthcare at Boehringer Ingelheim
As the pharma industry becomes more focussed on personalised medicines Dr Joachim Hasenmaier, Corporate Board Divisions Animal Health and Consumer Healthcare at Boehringer Ingelheim explains to Fintan Walton how they plan to grow the business through dedicated Animal Health R&D.
Boehringer Ingelheim
Boehringer Ingelheim
Boehringer Ingelheim GmbH is a pharmaceutical company which concentrates on the development of human pharmaceuticals, biopharmaceuticals, chemicals, and animal health products. The Human Pharmaceuticals sector is the company's largest division, accounting for about 96% of sales. This includes prescription medicines and consumer healthcare products.